Engineers Gate Manager LP Intercept Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$12.53 - $21.71 $218,360 - $378,340	-17,427 Reduced 35.07%	32,268 $433,000
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $8,068 - $11,196	-695 Reduced 1.38%	49,695 $614,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $615,261 - $992,683	50,390 New	50,390 $703,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $167,392 - $222,730	-12,520 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $87,008 - $118,996	-6,093 Reduced 32.74%	12,520 $204,000
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $98,762 - $155,633	7,603 Added 69.06%	18,613 $276,000
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $117,496 - $186,200	-7,600 Reduced 40.84%	11,010 $220,000
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $714,823 - $1.4 Million	-36,980 Reduced 66.52%	18,610 $430,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $392,169 - $680,369	16,020 Added 40.49%	55,590 $1.37 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $343,796 - $470,004	8,795 Added 28.58%	39,570 $1.64 Million
Q2 2020 Aug 17, 2020	BUY	$46.7 - $92.04 $349,129 - $688,091	7,476 Added 32.09%	30,775 $1.47 Million
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $1.13 Million - $2.77 Million	23,299 New	23,299 $1.47 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.